Evidence map›Paper›PMID 24657826›Full record

ArticleCirculation. Cardiovascular imaging2014

Near-infrared II fluorescence for imaging hindlimb vessel regeneration with dynamic tissue perfusion measurement.

Guosong Hong, Jerry C Lee, Arshi Jha, Shuo Diao, Karina H Nakayama, Luqia Hou, Timothy C Doyle, Joshua T Robinson, Alexander L Antaris, Hongjie Dai and 2 more

Open access · greenAbstract read
In one paragraph

Article in Circulation. Cardiovascular imaging, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 94 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Vascularization in tissue engineering: fundamentals and state-of-art.Progress in biomedical engineering (Bristol, England) · 2020
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Guosong HongFrom the School of Medicine, Division of Cardiovascular Medicine (J.C.L., A.J., J.P.C., N.F.H.), Department of Pediatrics (T.C.D.), Department of Chemistry (G.H., S.D., J.T.R., A.L.A., H.D.), and Cardiovascular Institute (K.H.N., L.H., H.D., J.P.C., N.F.H.), Stanford University, CA; and Veteran Affairs Palo Alto Health Care System, Palo Alto, CA (K.H.N., L.H., N.F.H.).
Jerry C LeeFrom the School of Medicine, Division of Cardiovascular Medicine (J.C.L., A.J., J.P.C., N.F.H.), Department of Pediatrics (T.C.D.), Department of Chemistry (G.H., S.D., J.T.R., A.L.A., H.D.), and Cardiovascular Institute (K.H.N., L.H., H.D., J.P.C., N.F.H.), Stanford University, CA; and Veteran Affairs Palo Alto Health Care System, Palo Alto, CA (K.H.N., L.H., N.F.H.).
Arshi JhaFrom the School of Medicine, Division of Cardiovascular Medicine (J.C.L., A.J., J.P.C., N.F.H.), Department of Pediatrics (T.C.D.), Department of Chemistry (G.H., S.D., J.T.R., A.L.A., H.D.), and Cardiovascular Institute (K.H.N., L.H., H.D., J.P.C., N.F.H.), Stanford University, CA; and Veteran Affairs Palo Alto Health Care System, Palo Alto, CA (K.H.N., L.H., N.F.H.).
Shuo DiaoFrom the School of Medicine, Division of Cardiovascular Medicine (J.C.L., A.J., J.P.C., N.F.H.), Department of Pediatrics (T.C.D.), Department of Chemistry (G.H., S.D., J.T.R., A.L.A., H.D.), and Cardiovascular Institute (K.H.N., L.H., H.D., J.P.C., N.F.H.), Stanford University, CA; and Veteran Affairs Palo Alto Health Care System, Palo Alto, CA (K.H.N., L.H., N.F.H.).
Karina H NakayamaFrom the School of Medicine, Division of Cardiovascular Medicine (J.C.L., A.J., J.P.C., N.F.H.), Department of Pediatrics (T.C.D.), Department of Chemistry (G.H., S.D., J.T.R., A.L.A., H.D.), and Cardiovascular Institute (K.H.N., L.H., H.D., J.P.C., N.F.H.), Stanford University, CA; and Veteran Affairs Palo Alto Health Care System, Palo Alto, CA (K.H.N., L.H., N.F.H.).
Luqia HouFrom the School of Medicine, Division of Cardiovascular Medicine (J.C.L., A.J., J.P.C., N.F.H.), Department of Pediatrics (T.C.D.), Department of Chemistry (G.H., S.D., J.T.R., A.L.A., H.D.), and Cardiovascular Institute (K.H.N., L.H., H.D., J.P.C., N.F.H.), Stanford University, CA; and Veteran Affairs Palo Alto Health Care System, Palo Alto, CA (K.H.N., L.H., N.F.H.).
Timothy C DoyleFrom the School of Medicine, Division of Cardiovascular Medicine (J.C.L., A.J., J.P.C., N.F.H.), Department of Pediatrics (T.C.D.), Department of Chemistry (G.H., S.D., J.T.R., A.L.A., H.D.), and Cardiovascular Institute (K.H.N., L.H., H.D., J.P.C., N.F.H.), Stanford University, CA; and Veteran Affairs Palo Alto Health Care System, Palo Alto, CA (K.H.N., L.H., N.F.H.).
Joshua T RobinsonFrom the School of Medicine, Division of Cardiovascular Medicine (J.C.L., A.J., J.P.C., N.F.H.), Department of Pediatrics (T.C.D.), Department of Chemistry (G.H., S.D., J.T.R., A.L.A., H.D.), and Cardiovascular Institute (K.H.N., L.H., H.D., J.P.C., N.F.H.), Stanford University, CA; and Veteran Affairs Palo Alto Health Care System, Palo Alto, CA (K.H.N., L.H., N.F.H.).
Alexander L AntarisFrom the School of Medicine, Division of Cardiovascular Medicine (J.C.L., A.J., J.P.C., N.F.H.), Department of Pediatrics (T.C.D.), Department of Chemistry (G.H., S.D., J.T.R., A.L.A., H.D.), and Cardiovascular Institute (K.H.N., L.H., H.D., J.P.C., N.F.H.), Stanford University, CA; and Veteran Affairs Palo Alto Health Care System, Palo Alto, CA (K.H.N., L.H., N.F.H.).
Hongjie DaiFrom the School of Medicine, Division of Cardiovascular Medicine (J.C.L., A.J., J.P.C., N.F.H.), Department of Pediatrics (T.C.D.), Department of Chemistry (G.H., S.D., J.T.R., A.L.A., H.D.), and Cardiovascular Institute (K.H.N., L.H., H.D., J.P.C., N.F.H.), Stanford University, CA; and Veteran Affairs Palo Alto Health Care System, Palo Alto, CA (K.H.N., L.H., N.F.H.).
John P CookeFrom the School of Medicine, Division of Cardiovascular Medicine (J.C.L., A.J., J.P.C., N.F.H.), Department of Pediatrics (T.C.D.), Department of Chemistry (G.H., S.D., J.T.R., A.L.A., H.D.), and Cardiovascular Institute (K.H.N., L.H., H.D., J.P.C., N.F.H.), Stanford University, CA; and Veteran Affairs Palo Alto Health Care System, Palo Alto, CA (K.H.N., L.H., N.F.H.).
Ngan F HuangFrom the School of Medicine, Division of Cardiovascular Medicine (J.C.L., A.J., J.P.C., N.F.H.), Department of Pediatrics (T.C.D.), Department of Chemistry (G.H., S.D., J.T.R., A.L.A., H.D.), and Cardiovascular Institute (K.H.N., L.H., H.D., J.P.C., N.F.H.), Stanford University, CA; and Veteran Affairs Palo Alto Health Care System, Palo Alto, CA (K.H.N., L.H., N.F.H.). ngantina@stanford.edu.
VA Palo Alto Health Care System · US

Funding

Basic and Translational Research iPSC-based hematologic and vascular therapiesU01HL100397 · NHLBI · STANFORD UNIVERSITY · PI COOKE, JOHN P · 2009 to 2015
$7.4M
T32 Training Program in Mechanisms and Innovation in Vascular DiseaseT32HL098049 · NHLBI · STANFORD UNIVERSITY · PI Nicholas James Leeper, Philip S Tsao · 2010 to 2026
$6.3M
NCE-based strategy for nuclear reprogramming and regenerative medicineRC2HL103400 · NHLBI · STANFORD UNIVERSITY · PI COOKE, JOHN P · 2009 to 2010
$2.7M
Carbon Nanotubes as Multi-functional Spectroscopic Markers and Delivery Agents foR01CA135109 · NCI · STANFORD UNIVERSITY · PI DAI, HONGJIE · 2008 to 2012
$1.6M
Matrix-mediated endothelial differentiation of induced pluripotent stem cellsR00HL098688 · NHLBI · PALO ALTO VETERANS INSTIT FOR RESEARCH · PI HUANG, NGAN F. · 2013 to 2016
$742k
Matrix-mediated endothelial differentiation of induced pluripotent stem cellsK99HL098688 · NHLBI · STANFORD UNIVERSITY · PI HUANG, NGAN F. · 2010 to 2011
$266k
NCI NIH HHS 5R01CA135109-02NCI NIH HHS R01 CA135109NHLBI NIH HHS K99 HL098688NHLBI NIH HHS R00 HL098688NHLBI NIH HHS R00HL098688NHLBI NIH HHS RC2 HL103400NHLBI NIH HHS RC2HL103400NHLBI NIH HHS T32 HL098049NHLBI NIH HHS U01 HL100397NHLBI NIH HHS U01HL100397
6 · The paper itself

Abstract

backgroundReal-time vascular imaging that provides both anatomic and hemodynamic information could greatly facilitate the diagnosis of vascular diseases and provide accurate assessment of therapeutic effects. Here, we have developed a novel fluorescence-based all-optical method, named near-infrared II (NIR-II) fluorescence imaging, to image murine hindlimb vasculature and blood flow in an experimental model of peripheral arterial disease, by exploiting fluorescence in the NIR-II region (1000-1400 nm) of photon wavelengths. METHODS AND

resultsBecause of the reduced photon scattering of NIR-II fluorescence compared with traditional NIR fluorescence imaging and thus much deeper penetration depth into the body, we demonstrated that the mouse hindlimb vasculature could be imaged with higher spatial resolution than in vivo microscopic computed tomography. Furthermore, imaging during 26 days revealed a significant increase in hindlimb microvascular density in response to experimentally induced ischemia within the first 8 days of the surgery (P<0.005), which was confirmed by histological analysis of microvascular density. Moreover, the tissue perfusion in the ischemic hindlimb could be quantitatively measured by the dynamic NIR-II method, revealing the temporal kinetics of blood flow recovery that resembled microbead-based blood flowmetry and laser Doppler blood spectroscopy.

conclusionsThe penetration depth of millimeters, high spatial resolution, and fast acquisition rate of NIR-II imaging make it a useful imaging tool for murine models of vascular disease.

Indexed as

FluorescenceAnimalsBlood Flow VelocityCollateral CirculationDisease Models, AnimalFemaleHemodynamicsHindlimbInfrared RaysMiceMice, NudeMicrovesselsOptical ImagingPeripheral Arterial DiseaseTomography, X-Ray Computedangiographyhemodynamicsnanotubes, carbon

Identifiers

PMID24657826
PMCPMC4079035
OpenAlexW2323223594

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.